See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
First Hawaiian, Inc. (FHB) - free report >>
Denali Therapeutics Inc. (DNLI) - free report >>
Guardant Health, Inc. (GH) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
First Hawaiian, Inc. (FHB) - free report >>
Denali Therapeutics Inc. (DNLI) - free report >>
Guardant Health, Inc. (GH) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 7th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Accolade, Inc. (ACCD - Free Report) provides personalized, technology-enabled solutions. The Zacks Consensus Estimate for its current year earnings has been revised 13.5% downward over the last 30 days.
Denali Therapeutics Inc. (DNLI - Free Report) is a biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 1.1% downward over the last 30 days.
Fastly, Inc. (FSLY - Free Report) provides infrastructure software. The Zacks Consensus Estimate for its current year earnings has been revised 2.4% downward over the last 30 days.
First Hawaiian, Inc. (FHB - Free Report) operates as a bank holding company for First Hawaiian Bank. The Zacks Consensus Estimate for its current year earnings has been revised 0.5% downward over the last 30 days.
Guardant Health, Inc. (GH - Free Report) is a precision oncology company. The Zacks Consensus Estimate for its current year earnings has been revised 2.5% downward over the last 30 days.
View the entire Zacks Rank #5 List.